Cargando…

Altered fecal bile acid composition in active ulcerative colitis

BACKGROUND: Disturbed bile acid homeostasis associated with a rise of primary and a decline of secondary bile acids is a consistent finding in inflammatory bowel diseases (IBDs). Whether fecal bile acids may emerge as biomarkers for IBD diagnosis and disease severity is less clear. Our study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommersberger, Stefanie, Gunawan, Stefan, Elger, Tanja, Fererberger, Tanja, Loibl, Johanna, Huss, Muriel, Kandulski, Arne, Krautbauer, Sabrina, Müller, Martina, Liebisch, Gerhard, Buechler, Christa, Tews, Hauke Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656844/
https://www.ncbi.nlm.nih.gov/pubmed/37980492
http://dx.doi.org/10.1186/s12944-023-01971-4
_version_ 1785148082956009472
author Sommersberger, Stefanie
Gunawan, Stefan
Elger, Tanja
Fererberger, Tanja
Loibl, Johanna
Huss, Muriel
Kandulski, Arne
Krautbauer, Sabrina
Müller, Martina
Liebisch, Gerhard
Buechler, Christa
Tews, Hauke Christian
author_facet Sommersberger, Stefanie
Gunawan, Stefan
Elger, Tanja
Fererberger, Tanja
Loibl, Johanna
Huss, Muriel
Kandulski, Arne
Krautbauer, Sabrina
Müller, Martina
Liebisch, Gerhard
Buechler, Christa
Tews, Hauke Christian
author_sort Sommersberger, Stefanie
collection PubMed
description BACKGROUND: Disturbed bile acid homeostasis associated with a rise of primary and a decline of secondary bile acids is a consistent finding in inflammatory bowel diseases (IBDs). Whether fecal bile acids may emerge as biomarkers for IBD diagnosis and disease severity is less clear. Our study aimed to identify associations of 18 fecal bile acid species with IBD entity and disease activity. METHODS: Stool samples of 62 IBD patients and 17 controls were collected. Eighteen fecal bile acid species were quantified by LC–MS/MS using stable isotope dilution. Lipid levels normalized to a dry weight of the fecal homogenates and ratios of single bile acid species to total bile acid levels were used for calculations. RESULTS: IBD patients exhibited altered primary and secondary bile acid ratios in stool, with notable distinctions between ulcerative colitis (UC) compared to Crohn’s disease (CD) and healthy controls. Fecal calprotectin was negatively correlated with glycolithocholic acid (GLCA) and hyodeoxycholic acid (HDCA) in UC. These bile acids were reduced in stool of UC patients with fecal calprotectin levels > 500 µg/g compared to UC patients with low calprotectin levels. Moreover, negative associations of six secondary bile acids with C-reactive protein (CRP) existed in UC. In CD patients, fecal bile acids did not correlate with CRP or fecal calprotectin. Diarrhoea is common in IBD, and UC patients with diarrhoea had reduced deoxycholic acid (DCA), glycine conjugated DCA (GDCA) and lithocholic acid in stool in contrast to patients with normal stool consistency. Fecal bile acid levels were not associated with diarrhoea in CD patients. UC patients treated with mesalazine had increased levels of fecal GDCA whereas no such changes were observed in CD patients. Bile acid levels of CD and UC patients treated with biologicals or corticosteroids did not change. Relative levels of GHDCA (specificity: 79%, sensitivity: 67%) and glycochenodeoxycholic acid (specificity: 74%, sensitivity: 63%) were the most specific to distinguish UC from CD. CONCLUSION: Disrupted fecal bile acid homeostasis is associated with disease severity and disease symptoms in UC but not in CD, potentially aiding in distinguishing IBD subtypes and classifying the pathophysiology of diarrhoea in UC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01971-4.
format Online
Article
Text
id pubmed-10656844
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106568442023-11-18 Altered fecal bile acid composition in active ulcerative colitis Sommersberger, Stefanie Gunawan, Stefan Elger, Tanja Fererberger, Tanja Loibl, Johanna Huss, Muriel Kandulski, Arne Krautbauer, Sabrina Müller, Martina Liebisch, Gerhard Buechler, Christa Tews, Hauke Christian Lipids Health Dis Research BACKGROUND: Disturbed bile acid homeostasis associated with a rise of primary and a decline of secondary bile acids is a consistent finding in inflammatory bowel diseases (IBDs). Whether fecal bile acids may emerge as biomarkers for IBD diagnosis and disease severity is less clear. Our study aimed to identify associations of 18 fecal bile acid species with IBD entity and disease activity. METHODS: Stool samples of 62 IBD patients and 17 controls were collected. Eighteen fecal bile acid species were quantified by LC–MS/MS using stable isotope dilution. Lipid levels normalized to a dry weight of the fecal homogenates and ratios of single bile acid species to total bile acid levels were used for calculations. RESULTS: IBD patients exhibited altered primary and secondary bile acid ratios in stool, with notable distinctions between ulcerative colitis (UC) compared to Crohn’s disease (CD) and healthy controls. Fecal calprotectin was negatively correlated with glycolithocholic acid (GLCA) and hyodeoxycholic acid (HDCA) in UC. These bile acids were reduced in stool of UC patients with fecal calprotectin levels > 500 µg/g compared to UC patients with low calprotectin levels. Moreover, negative associations of six secondary bile acids with C-reactive protein (CRP) existed in UC. In CD patients, fecal bile acids did not correlate with CRP or fecal calprotectin. Diarrhoea is common in IBD, and UC patients with diarrhoea had reduced deoxycholic acid (DCA), glycine conjugated DCA (GDCA) and lithocholic acid in stool in contrast to patients with normal stool consistency. Fecal bile acid levels were not associated with diarrhoea in CD patients. UC patients treated with mesalazine had increased levels of fecal GDCA whereas no such changes were observed in CD patients. Bile acid levels of CD and UC patients treated with biologicals or corticosteroids did not change. Relative levels of GHDCA (specificity: 79%, sensitivity: 67%) and glycochenodeoxycholic acid (specificity: 74%, sensitivity: 63%) were the most specific to distinguish UC from CD. CONCLUSION: Disrupted fecal bile acid homeostasis is associated with disease severity and disease symptoms in UC but not in CD, potentially aiding in distinguishing IBD subtypes and classifying the pathophysiology of diarrhoea in UC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01971-4. BioMed Central 2023-11-18 /pmc/articles/PMC10656844/ /pubmed/37980492 http://dx.doi.org/10.1186/s12944-023-01971-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sommersberger, Stefanie
Gunawan, Stefan
Elger, Tanja
Fererberger, Tanja
Loibl, Johanna
Huss, Muriel
Kandulski, Arne
Krautbauer, Sabrina
Müller, Martina
Liebisch, Gerhard
Buechler, Christa
Tews, Hauke Christian
Altered fecal bile acid composition in active ulcerative colitis
title Altered fecal bile acid composition in active ulcerative colitis
title_full Altered fecal bile acid composition in active ulcerative colitis
title_fullStr Altered fecal bile acid composition in active ulcerative colitis
title_full_unstemmed Altered fecal bile acid composition in active ulcerative colitis
title_short Altered fecal bile acid composition in active ulcerative colitis
title_sort altered fecal bile acid composition in active ulcerative colitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656844/
https://www.ncbi.nlm.nih.gov/pubmed/37980492
http://dx.doi.org/10.1186/s12944-023-01971-4
work_keys_str_mv AT sommersbergerstefanie alteredfecalbileacidcompositioninactiveulcerativecolitis
AT gunawanstefan alteredfecalbileacidcompositioninactiveulcerativecolitis
AT elgertanja alteredfecalbileacidcompositioninactiveulcerativecolitis
AT fererbergertanja alteredfecalbileacidcompositioninactiveulcerativecolitis
AT loibljohanna alteredfecalbileacidcompositioninactiveulcerativecolitis
AT hussmuriel alteredfecalbileacidcompositioninactiveulcerativecolitis
AT kandulskiarne alteredfecalbileacidcompositioninactiveulcerativecolitis
AT krautbauersabrina alteredfecalbileacidcompositioninactiveulcerativecolitis
AT mullermartina alteredfecalbileacidcompositioninactiveulcerativecolitis
AT liebischgerhard alteredfecalbileacidcompositioninactiveulcerativecolitis
AT buechlerchrista alteredfecalbileacidcompositioninactiveulcerativecolitis
AT tewshaukechristian alteredfecalbileacidcompositioninactiveulcerativecolitis